26.87
price down icon0.11%   -0.03
after-market 시간 외 거래: 26.65 -0.22 -0.82%
loading
전일 마감가:
$26.90
열려 있는:
$27.09
하루 거래량:
103.56K
Relative Volume:
0.53
시가총액:
$696.68M
수익:
-
순이익/손실:
$11.77M
주가수익비율:
-173.69
EPS:
-0.1547
순현금흐름:
$-19.23M
1주 성능:
-0.85%
1개월 성능:
+0.52%
6개월 성능:
+69.63%
1년 성능:
+60.13%
1일 변동 폭
Value
$26.65
$27.68
1주일 범위
Value
$25.10
$27.68
52주 변동 폭
Value
$12.12
$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
명칭
Tourmaline Bio Inc
Name
전화
646-481-9832
Name
주소
27 WEST 24TH STREET, NEW YORK
Name
직원
58
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TRML's Discussions on Twitter

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-15 개시 Jefferies Buy
2023-12-04 재개 H.C. Wainwright Buy
2023-11-17 개시 Truist Buy
2023-10-31 개시 Guggenheim Buy
2023-10-25 개시 Piper Sandler Overweight
2022-10-20 개시 H.C. Wainwright Buy
2022-07-05 다운그레이드 Morgan Stanley Overweight → Equal-Weight
모두보기

Tourmaline Bio Inc 주식(TRML)의 최신 뉴스

pulisher
08:08 AM

AlphaCentric Advisors LLC Sells 69,500 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

08:08 AM
pulisher
01:25 AM

Tourmaline Bio shares get buy rating on IL-6 study optimism - Investing.com Canada

01:25 AM
pulisher
Nov 02, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, Q - GuruFocus.com

Nov 02, 2024
pulisher
Oct 31, 2024

The Best Curling Irons, Based On Several Months Of Testing - Forbes

Oct 31, 2024
pulisher
Oct 31, 2024

Tourmaline Bio to Present at Upcoming Investor Conferences - The Manila Times

Oct 31, 2024
pulisher
Oct 27, 2024

Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Declines By 20.0% - MarketBeat

Oct 27, 2024
pulisher
Oct 18, 2024

Cantor Fitzgerald Predicts Tourmaline Bio FY2024 Earnings - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Tourmaline Bio, Inc. to Post FY2024 Earnings of ($2.85) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:TRML) - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Cantor Fitzgerald Upgrades Tourmaline Bio (NASDAQ:TRML) to “Strong-Buy” - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Up 6.3%Here's What Happened - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Tourmaline Bio Insiders Placed Bullish Bets Worth US$643.3k - Simply Wall St

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Cantor Fitzgerald Upgrades Tourmaline Bio (NASDAQ:TRML) to Strong-Buy - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com Canada

Oct 16, 2024
pulisher
Oct 15, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap UpStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024 - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in ... - The Bakersfield Californian

Oct 15, 2024
pulisher
Oct 14, 2024

TRMLTourmaline Bio, Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Investing in Tourmaline Bio Inc (TRML): What You Must Know - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting (NASDAQ:TRML) - Seeking Alpha

Oct 13, 2024
pulisher
Oct 13, 2024

Cubist Systematic Strategies LLC Purchases Shares of 37,861 Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap Down – Time to Sell? - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap DownTime to Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Guggenheim reiterates Buy on Tourmaline Bio shares, keeps price target By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress - The Manila Times

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio announces CMO resignation By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 10, 2024

Tourmaline Bio announces CMO resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio’s Chief Medical Officer Resigns Amicably - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. Announces Resignation of Yung Chyung as Chief Medical Officer,Effective October 31, 2024 - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Marquette Asset Management LLC Raises Stake in Vera Bradley, Inc. (NASDAQ:VRA) - Defense World

Oct 09, 2024
pulisher
Oct 09, 2024

Tourmaline Bio (NASDAQ:TRML) Stock Price Down 4.3%Should You Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Tourmaline Bio (NASDAQ:TRML) Trading 6.4% HigherStill a Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio (NASDAQ:TRML) Trading 6.4% Higher – What’s Next? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio forms advisory board for heart drug By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio forms Cardiovascular Scientific Advisory Board - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board - The Manila Times

Oct 08, 2024
pulisher
Oct 07, 2024

Algert Global LLC Has $513,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Oct 07, 2024
pulisher
Oct 03, 2024

There is no way Tourmaline Bio Inc (TRML) can keep these numbers up - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

Keeping an Eye on Tourmaline Bio Inc (TRML) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Did Tourmaline Bio Inc (TRML) perform well in the last session? - US Post News

Oct 02, 2024
pulisher
Oct 02, 2024

Keeping an Eye on PubMatic Inc (PUBM) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Neogenomics Inc. (NEO) - Knox Daily

Oct 02, 2024
pulisher
Oct 01, 2024

Crew Energy Inc. Announces Completion of Acquisition By Tourmaline Oil Corp. - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Graves’ Disease Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight - The Globe and Mail

Sep 30, 2024
pulisher
Sep 28, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Boosted by Blue Owl Capital Holdings LP - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Rhumbline Advisers - MarketBeat

Sep 27, 2024

Tourmaline Bio Inc (TRML) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Tourmaline Bio Inc 주식 (TRML) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Kulkarni Sandeep Chidambar
CEO
Aug 16 '24
Buy
13.79
5,221
71,998
5,221
MCDADE MARK
Director
Jan 29 '24
Buy
32.50
100,000
3,250,000
448,431
Kulkarni Sandeep Chidambar
CEO
Nov 17 '23
Buy
16.99
4,000
67,960
729,735
Thiara Parvinder
Director
Nov 17 '23
Buy
17.31
1,000
17,310
83,782
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):